Ensysce Biosciences (ENSC) EPS (Basic) (2018 - 2025)
Ensysce Biosciences' (ENSC) quarterly EPS (Basic) came in at -$1.29 in Q3 2025, down 228.75% year-over-year from $1.0 in Q3 2024, and down 64.17% quarter-over-quarter from -$0.79 in Q2 2025.
Powered by 
Analysis
Ensysce Biosciences (ENSC) EPS (Basic) (2018 - 2025) Analysis & Trends
Ensysce Biosciences (ENSC) has reported EPS (Basic) for 8 consecutive years, with -$1.29 the latest figure, recorded in Q3 2025.
- On a quarterly basis, EPS (Basic) fell 228.75% year-over-year to -$1.29 in Q3 2025; TTM through Sep 2025 was -$3.8, a 68.38% increase from a year earlier, with the FY2024 full-year figure at -$11.45, up 83.74% from the prior year.
- EPS (Basic) was -$1.29 for Q3 2025 at Ensysce Biosciences, down from -$0.79 in the prior quarter.
- Over five years, EPS (Basic) peaked at $1.0 in Q3 2024 and troughed at -$2547.3 in Q3 2021.
- A 5-year average of -$408.95 and a median of -$23.22 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) slumped 1699.89% in 2021 and surged 107.68% in 2024, its largest moves.
- Over 5 years, EPS (Basic) stood at -$1935.4 in 2021, then soared by 76.22% to -$460.31 in 2022, then jumped by 94.96% to -$23.22 in 2023, then jumped by 77.99% to -$5.11 in 2024, then surged by 74.71% to -$1.29 in 2025.
- The last three EPS (Basic) figures came in at -$1.29 (Q3 2025), -$0.79 (Q2 2025), and -$1.39 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 1.68 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -3.06 |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 2.92 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 7.82 |
| 10 | Ensysce Biosciences | 1.20 Mn | -3.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1.29 |
| Jun 30, 2025 | -0.79 |
| Mar 31, 2025 | -1.39 |
| Dec 31, 2024 | -5.11 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | -3.35 |
| Mar 31, 2024 | -8.21 |
| Dec 31, 2023 | -23.22 |
| Sep 30, 2023 | -13.07 |
| Jun 30, 2023 | -14.75 |
| Mar 31, 2023 | -31.25 |
| Dec 31, 2022 | -460.31 |
| Sep 30, 2022 | -923.72 |
| Jun 30, 2022 | -847.29 |
| Mar 31, 2022 | -219.88 |
| Dec 31, 2021 | -1,935.38 |
| Sep 30, 2021 | -2,547.27 |
| Jun 30, 2021 | -209.81 |
| Mar 31, 2021 | -525.00 |
| Dec 31, 2020 | 120.97 |